ReCAP: Impact of the National Cancer Institute Community Cancer Centers Program on Clinical Trial and Related Activities at a Community Cancer Center in Rural Nebraska Over a 1-year period, the mean ...

Evaluation of inducible expression of ERCC1 as a biomarker of drug response in human colorectal cancer cell lines. Background: Although in use for almost 30 years, the clinical value of CEA as the ...

A novel intelligent biosensing platform consisting of quantum dots luminescence and biochip with machine vision algorithm is proposed for point-of-care carcinoembryonic antigen (CEA) protein ...

Researchers have identified a blood protein that can be used as a marker of gastric and other cancers and is more accurate than existing diagnostic biomarkers, even in the early stages of the disease.